| 7.99 -0.11 (-1.36%) | 06-09 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 10.54 | 1-year : | 12.31 |
| Resists | First : | 9.02 | Second : | 10.54 |
| Pivot price | 8.03  |
|||
| Supports | First : | 7.47 | Second : | 6.51 |
| MAs | MA(5) : | 8.3  |
MA(20) : | 7.82 |
| MA(100) : | 6.88 |
MA(250) : | 6.8 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 59.3 |
D(3) : | 69.1 |
| RSI | RSI(14): 52.2 |
|||
| 52-week | High : | 9.34 | Low : | 5.02 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ MASS ] has closed above bottom band by 48.3%. Bollinger Bands are 77.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 22 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 8.38 - 8.43 | 8.43 - 8.46 |
| Low: | 7.49 - 7.54 | 7.54 - 7.58 |
| Close: | 7.91 - 8 | 8 - 8.06 |
908 Devices Inc. is an established technology company providing advanced mass spectrometry (Mass Spec) solutions. They develop specialized portable and benchtop instruments designed to analyze and identify unknown or hidden substances across various fields. Their products address needs in life sciences research, biopharmaceutical manufacturing, industrial biotechnology, forensic investigations, and related sectors. Key offerings include: The MX908, a handheld, battery-operated Mass Spec device capable of rapid on-site detection and identification of unknown gaseous, liquid, and solid materials. The Rebel, a compact desktop analyzer that delivers real-time data concerning the extracellular environment within bioprocesses. The ZipChip solution, a high-resolution, user-friendly separation platform engineered to optimize the preparation and analysis of samples for Mass Spec. With operations spanning the globe, 908 Devices Inc. serves markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was established in 2012 and is based in Boston, Massachusetts.
Fri, 05 Jun 2026
Insider Sell: Christopher Brown Sells Shares of 908 Devices Inc (MASS) - GuruFocus
Fri, 05 Jun 2026
908 devices director Christopher Brown sells $900 in stock - Investing.com
Fri, 05 Jun 2026
908 Devices (MASS) director logs small 100-share sale under 10b5-1 plan - Stock Titan
Fri, 05 Jun 2026
ARK and Cathie Wood report 1.88M shares in 908 Devices (MASS) - Stock Titan
Thu, 04 Jun 2026
Insider Sell: Christopher Brown Sells 20,000 Shares of 908 Devices Inc (MASS) - GuruFocus
Thu, 04 Jun 2026
Director at 908 Devices (NASDAQ: MASS) sells 20,000 shares under 10b5-1 plan - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 38 (M) |
| Shares Float | 24 (M) |
| Held by Insiders | 8.9 (%) |
| Held by Institutions | 90.6 (%) |
| Shares Short | 3,340 (K) |
| Shares Short P.Month | 3,480 (K) |
| EPS | -0.98 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.96 |
| Profit Margin | -62.5 % |
| Operating Margin | -48.6 % |
| Return on Assets (ttm) | -7.6 % |
| Return on Equity (ttm) | -24.2 % |
| Qtrly Rev. Growth | 13.6 % |
| Gross Profit (p.s.) | 0.79 |
| Sales Per Share | 1.52 |
| EBITDA (p.s.) | -0.5 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -7 (M) |
| Levered Free Cash Flow | 14 (M) |
| PE Ratio | -8.24 |
| PEG Ratio | 0 |
| Price to Book value | 2.01 |
| Price to Sales | 5.22 |
| Price to Cash Flow | -40.5 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|